GPT-Rosalind (OpenAI) vs Kimi K2.5 (Moonshot)
Which one should you pick? Here's the full breakdown.
GPT-Rosalind (OpenAI)
OpenAI's first domain-specific model -- life sciences, drug discovery, translational medicine. Launched 2026-04-16 as a Trusted Access research preview. Launch partners: Amgen, Moderna, Allen Institute, Thermo Fisher. Paired with a Life Sciences Codex plugin (50+ scientific tool integrations)
Kimi K2.5 (Moonshot)
Moonshot's 1T-parameter MoE open-weights flagship -- best open-source agentic coder, rivals Claude Opus 4.5
| Category | GPT-Rosalind (OpenAI) | Kimi K2.5 (Moonshot) |
|---|---|---|
| Ease of Use | 3.0 | 6.0 |
| Output Quality | 9.0 | 9.0 |
| Value | 7.0 | 8.5 |
| Features | 8.0 | 9.0 |
| Overall | 6.8 | 8.1 |
Pricing Comparison
| Feature | GPT-Rosalind (OpenAI) | Kimi K2.5 (Moonshot) |
|---|---|---|
| Free Tier | No | Yes |
| Starting Price | Invite only | $0 |
Benchmark Head-to-Head
Kimi K2.5 (1T/32B active MoE) benchmarks — GPT-Rosalind (OpenAI) has no published benchmarks
| Benchmark | Description | Score |
|---|---|---|
| MMLU-Pro | Harder multi-subject reasoning | 84.8% |
| GPQA Diamond | Graduate-level science questions | 80.5% |
| AIME 2025 | 91.2% | |
| SWE-Bench Verified | 78.5% | |
| LiveCodeBench | 74.1% |
Which Should You Pick?
Pick GPT-Rosalind (OpenAI) if...
Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.
Visit GPT-Rosalind (OpenAI)Pick Kimi K2.5 (Moonshot) if...
- ✓Easier to use (6 vs 3)
- ✓Better value for money (8.5/10)
- ✓More features (9 vs 8)
- ✓Has a free tier
Agentic coding workflows, tool-use agents, and teams willing to pay hosted-API prices for frontier-tier quality with open-weights licensing protection.
Visit Kimi K2.5 (Moonshot)Our Verdict
Kimi K2.5 (Moonshot) is the clear winner here with 8.1/10 vs 6.8/10. GPT-Rosalind (OpenAI) isn't bad, but Kimi K2.5 (Moonshot) outperforms it across the board. Pick GPT-Rosalind (OpenAI) only if researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access.